Mologic (Bedford, UK) and BioSure (Essex, UK) have entered a partnership to produce an antibody self-test for COVID-19 that does not require specialist equipment or training to carry out.
A study led by researchers from Brussels Academic Hospital Lab (LHUB-ULB, Brussels, Belgium) indicates that the COVID-19 Ag Respi-Strip® – an antigen test for COVID-19 – could be a useful component in broader testing strategies.
Medicines Discovery Catapult (Cheshire, UK), Retrogenix (High Peak, UK) and Peak Proteins (Cheshire, UK) have entered a new three-way collaboration to identify potential target receptors for COVID-19 therapies.
Researchers from Icahn School of Medicine at Mount Sinai (NY, USA) have developed a step-by-step protocol for a serological test that can detect antibodies to SARS-CoV-2.
Results of a new multi-institutional study led by researchers at University of Illinois at Urbana-Champaign (IL, USA) indicate that a portable testing device clipped to a smartphone could detect pathogens in biological samples in minutes.
A real-time RT-PCR test for SARS-CoV-2 – the virus responsible for COVID-19 – developed by Seegene (Seoul, South Korea) is one of the latest assays to be granted emergency use authorization by the US FDA.
Genedrive (Manchester, UK) and Cytiva (formerly GE Healthcare; IL, USA) have entered an international collaboration to develop a one step assay to detect SARS-CoV-2 for use on lab-based PCR instruments.
Researchers from institutions across Korea have developed a rapid antibody test to detect SARS-CoV-2 based on a field-effect transistor. The test can distinguish healthy individuals’ nasopharyngeal swab samples from COVID-19 patients’ swabs with no sample preparation required.
Scientists from The University of Zurich (Switzerland) and Institute of Environmental Engineering (Zurich, Switzerland) have developed a diagnostic assay to detect RNA sequences from SARS-CoV-2, the virus responsible for COVID-19.
Researchers from the University of Pennsylvania School of Medicine (PA, USA) demonstrated in a multidisciplinary blinded study that a liquid biopsy was more accurate for detecting the early stages of pancreatic ductal adenocarcinoma other biomarkers alone.